Plasma-cell dyscrasia after alkylating-agent therapy for Hodgkin's disease.
D000328:Adult; D000368:Aged; D000477:Alkylating Agents / Q000009:adverse effects*; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D008297:Male; D010265:Paraproteinemias / Q000139:chemically induced*
D000477:Alkylating Agents